Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain

Behavioral Neuroscience

Volumn 119, Issue 4, 2005, Pages 1052-1060

  Conti, Lisa H ^a   Costill, Jennifer E ^a   Flynn, Sean ^a   Tayler, Jane E ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Acoustic startle; Antipsychotic; Corticotropin releasing factor; Prepulse inhibition; Rat strain

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; CORTICOTROPIN RELEASING FACTOR; HALOPERIDOL; NEUROLEPTIC AGENT; SODIUM CHLORIDE;

ACOUSTIC STARTLE RESPONSE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; HORMONE ACTION; MALE; NONHUMAN; PREPULSE INHIBITION; RAT; RAT STRAIN; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CLOZAPINE; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; HALOPERIDOL; HORMONES; INJECTIONS, INTRAVENTRICULAR; MALE; NEURAL INHIBITION; RATS; RATS, INBRED BN; RATS, INBRED WKY; STARTLE REACTION;

EID: 25444518191     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.119.4.1052     Document Type: Article

References (40)

1. Anokhin, A. P., Heath, A. C., Myers, E., Ralano, A., & Wood, S. (2003). Genetic influences on prepulse inhibition of the startle reflex in humans. Neuroscience Letters, 353, 45-48.
2. Bakshi, V. P., & Geyer, M. A. (1999). Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats. Neuroscience, 92, 113-121.
3. Bale, T. L., & Vale, W. W. (2004). CRF and CRF receptors: Role in stress responsivity and other behaviors. Annual Review of Pharmacology and Toxicology, 44, 525-557.
4. Berridge, C. W., & Dunn, A. J. (1989). CRF and restraint-stress decrease exploratory behavior in hypophysectomized mice. Pharmacology Biochemistry and Behavior, 34, 517-519.
5. Braff, D., Stone, C., Callaway, E., Geyer, M., Glick, I., & Bali, L. (1978). Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology, 15, 339-343.
6. Cadenhead, K. S., Swerdlow, N. R., Shafer, K. M., Diaz, M., & Braff, D. L. (2000). Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: Evidence of inhibitory deficits. American Journal of Psychiatry, 157, 1660-1668.
7. 1 receptor mRNA expression. Journal of Neuroscience, 15, 6340-6350.
8. Conti, L. H. (2005). Characterization of the effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats. European Journal of Pharmacology, 507, 125-134.
9. Conti, L. H., Murry, J. D., Ruiz, M. A., & Printz, M. P. (2002). Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains. Psychopharmacology. 161, 296-303.
10. Conti, L. H., Palmer, A. A., Vanella, J. J., & Printz, M. P. (2001). Latent inhibition and conditioning in rat strains which show differential prepulse inhibition. Behavior Genetics, 31, 325-333.
11. Depoortere, R., Perrault, G., & Sanger, D. J. (1997). Some, but not all, antipsychotic drugs potentiate a low level of prepulse inhibition shown by rats of the Wistar strain. Behavioural Pharmacology, 8, 364-372.
12. De Souza, E. B. (1987). Corticotropin-releasing factor receptors in the rat central nervous system: Characterization and regional distribution. Journal of Neuroscience, 7, 88-100.
13. Dirks, A., Groenink, L., Schipholt, M. I., van der Gugten, J., Hijzen, T. H., Geyer, M. A., & Oliver, B. (2002). Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone. Biological Psychiatry, 51, 583-590.
14. Dirks, A., Groenink, L., Westphal, K. G., Oliver, J. D., Verdouw, P. M., van der Gugtenm, J., et al. (2003). Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs. Neuropsychopharmacology, 28, 1790-1798.
15. Feifel, D., Melendez, G., & Shilling, P. D. (2004). Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not by haloperidol: A potential predictive model for novel antipsychotic effects. Neuropsychopharmacology, 29, 731-738.
16. Feifel, D., & Priebe, K. (2001). Vasopressin-deficient rats exhibit sensorimotor gating deficits that are reversed by subchronic haloperidol. Biological Psychiatry, 50, 425-433.
17. Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review. Psychopharmacology, 156, 117-154.
18. Geyer, M. A., Swerdlow, N. R., Mansbach, R. S., & Braff, D. L. (1990). Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Research Bulletin, 25, 625-648.
19. Gray, T. S. (1993). Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Annals of the New York Academy of Sciences, 697, 53-60.
20. Grillon, C., Morgan, C. A., Davis, M., & Southwick, S. M. (1998). Effects of experimental context and specific threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biological Psychiatry. 44, 1027-1036.
21. Hammond, G. R., Macadam, D. W., & Ison, J. R. (1972). Effects of prestimulation on the electromyographic response associated with the acoustic startle reaction in rats. Physiology and Behavior, 8, 535-537.
22. Johansson, C., Jackson, D. M., Zhang, J.. & Svensson, L. (1995). Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: Effects of antipsychotics and other agents in rats. Pharmacology Biochemistry and Behavior. 52, 649-654.
23. Jones, D. N. C., Kortekaas, R., Slade, P. D., Middlemiss, D. N., & Hagan, J. J. (1998). The behavioral effects of corticotropin-releasing factor-related peptides in rats. Psychopharmacology, 138, 124-132.
24. Kalivas, P. W., Duffy, P., & Latimer, L. G. (1987). Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. Journal of Pharmacology and Experimental Therapeutics, 242, 757-763.
25. Kohlaas, K. L., & Rueter, L. E. (2004). A rat model of a natural deficit in pre-pulse inhibition: Effective attenuation with antipsychotic treatment. Society for Neuroscience Abstracts, # 349.2.
26. Lavicky, J., & Dunn, A. J. (1993). Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats assessed by microdialysis. Journal of Neurochemistry, 60, 602-612.
27. Liang, K. C., Melia, K. R., Miserendino, M. J. D., Falls, W. A., Campeau, S., & Davis, M. (1992). Corticotropin-releasing factor. Long-lasting facilitation of the acoustic startle reflex. Journal of Neuroscience, 12, 2303-2312.
28. Mackeprang, T., Kristiansen, K. T., & Glenthoj, B. Y. (2002). Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients. Biological Psychiatry, 52, 863-873.
29. Mansbach, R. S., Geyer, M. A., & Braff, D. L. (1988). Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology, 94, 507-514.
30. Matsuzaki, I., Takamatsu, Y., & Moroji, T. (1989). The effects of intracerebroventrtcularly injected corticotropin-releasing factor (CRF) on the central nervous system: Behavioral and biochemical studies. Neuropeptides, 13, 147-155.
31. Page, M. E., & Abercrombie, E. D. (1999). Discrete local application of corticotropin-releasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus. Synapse, 33, 304-313.
32. Palmer, A. A., Dulawa, S. C., Mottiwala, A. A., Conti, L. H., Geyer, M. A., & Printz, M. P. (2000). Prepulse startle deficit in the Brown Norway rat: A potential genetic model. Behavioral Neuroscience, 114, 374-388.
33. Parwani, A., Duncan, E. J., Bartlett, E., Madonick, S. H., Efferen, T. R., Rajan, R., et al. (2000). Impaired prepulse inhibition of acoustic startle in schizophrenia. Biological Psychiatry, 47, 662-669.
34. Price, M. L., Curtis, A. L., Kirby, L. G., Valentino, R. J., & Lucki, I. (1998). Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology, 18, 492-502.
35. Radulovic, J., Sydow, S., & Spiess, J. (1998). Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system. Journal of Neuroscience Research, 54, 507-521.
36. Risbrough, V. B., Hauger, R. L., Pelleymounter, M. A., & Geyer, M. A. (2003). Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated startle in mice. Psychopharmacology, 170, 178-187.
37. 2 exert both additive and opposing influences on startle defensive behavior. Journal of Neuroscience, 24, 6545-6552.
38. Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (1983). Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology, 36, 165-186.
39. Swerdlow, N. R., Braff, D. L., Taaid, N., & Geyer, M. A. (1994). Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Archives of General Psychiatry, 51, 139-154.
40. Swerdlow, N. R., Britton, K. T., & Koob, G. F. (1989). Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by α-helical CRF (9-41). Neuropsychopharmacology, 2, 285-292.